Home LiteratureArticle Details
PMID: 11784881 Published · ppublish English Editorial Research Support, Non-U.S. Gov't Comment

Lung cancer--time to move on from chemotherapy.

The New England journal of medicine ·Vol. 346 ·No. 2 ·2002-01-10 ·Pages 126-8

Carney DN

Abstract

暂无摘要

MeSH Terms
Antineoplastic Combined Chemotherapy Protocols/therapeutic use Camptothecin/administration & dosage,analogs & derivatives Carcinoma, Non-Small-Cell Lung/drug therapy Carcinoma, Small Cell/drug therapy Cisplatin/administration & dosage Etoposide/administration & dosage Humans Irinotecan Lung Neoplasms/drug therapy,prevention & control Smoking/adverse effects Survival Rate
Chemicals
Etoposide Irinotecan Cisplatin Camptothecin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Carney Desmond N
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJM200201103460211
Published
2002-01-10
Pages
126-8
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 11784874
CommentOn
PMID: 11784875
External Links
PubMed source DOI: 10.1056/NEJM200201103460211 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2